Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well metformin hydrochloride works in preventing
esophageal cancer in patients with Barrett esophagus. Chemoprevention is the use of certain
drugs to keep cancer from forming. The use of metformin hydrochloride may keep esophageal
cancer from forming.